TTG Tutogen Medical,

ALACHUA, Fla., May 7 /PRNewswire-FirstCall/ -- Tutogen Medical, Inc. (AMEX:TTG), a leading manufacturer of sterile biological implant products made from human (allograft) and animal (xenograft) tissue, will report financial results for the second quarter ended March 31, 2007 on Monday, May 14, 2007 at 10:00 a.m. ET. Interested parties can access the call by dialing (800) 218-4007 or (303) 262-2137 or by accessing the web cast at http://www.tutogen.com/investor.asp. A replay of the call will be available at (800) 405-2236 or (303) 590-3000, conference ID number: 11089605 for 3 days following the call, and the web cast can be accessed at http://www.tutogen.com/investor.asp for 30 days. About Tutogen Medical, Inc. Tutogen Medical, Inc. manufactures sterile biological implant products made from human (allograft) and animal (xenograft) tissue. Tutogen utilizes its Tutoplast Process(R) of tissue preservation and viral inactivation to manufacture and deliver sterile bio-implants used in spinal/trauma, urology, dental, ophthalmology, and general surgery procedures. The Company's Tutoplast(R) products are sold and distributed worldwide by Zimmer Spine and Zimmer Dental, subsidiaries of Zimmer Holdings, Inc., Davol Inc. subsidiary of C.R. Bard Inc., the Mentor Corporation (Mentor), Coloplast Corp., IOP, Inc. and through independent distributors internationally. For more information, visit the Company's Web site at http://www.tutogen.com/. Contacts: L. Robert Johnston, Jr. Lytham Partners, LLC Chief Financial Officer Joe Diaz Tutogen Medical, Inc. Joe Dorame 386-462-0402 Robert Blum 602-889-9700 DATASOURCE: Tutogen Medical, Inc. CONTACT: L. Robert Johnston, Chief Financial Officer of Tutogen Medical, Inc., +1-386-462-0402, ; or Joe Diaz, or Joe Dorame, or Robert Blum, all of Lytham Partners, LLC, +1-602-889-9700, for Tutogen Medical, Inc. Web site: http://www.tutogen.com/

Copyright